SPY322.45-1.05 -0.32%
DIA267.21-0.89 -0.33%
IXIC10,643.74-28.53 -0.27%

CHF Solutions' Aquadex Products Granted Federal Supply Schedule Contract

EDEN PRAIRIE, Minn., Aug. 18, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (NASDAQ:CHFS), a medical device company dedicated to improving the lives of patients suffering from fluid overload, today announced that its

Benzinga · 08/18/2020 12:22

EDEN PRAIRIE, Minn., Aug. 18, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (NASDAQ:CHFS), a medical device company dedicated to improving the lives of patients suffering from fluid overload, today announced that its Aquadex™ product line has been added to the Federal Supply Schedule, expanding access to all federal government agencies, including the Department of Veterans Affairs (VA), Indian Health Services (IHS) and Department of Defense (DOD) Medical Treatment Facilities.
 

"Our goal is to provide access to the Aquadex therapy for all patients suffering from fluid overload. The inclusion on the Federal Supply Schedule is a significant milestone towards this goal by streamlining the purchasing process and allowing the therapy to be available for patients at all federal government facilities," said John Erb, CEO of CHF Solutions. "The Aquadex SmartFlow ultrafiltration system is a simple, flexible and smart fluid management platform that reduces fluid overload caused by a variety of conditions, including heart failure, COVID-19 and other critical care conditions. With this technology in hand, providers can use ultrafiltration to help mitigate life-threatening complications and manage their patients' fluid balance with precision, control and ease."

The Aquadex system has been used at individual VA hospitals for many years. In each case, the company has negotiated contracts with each individual facility. Now, in partnership with Downeast Logistics LLC, the Aquadex SmartFlow™ console and Aquadex FlexFlow® Blood Circuit Set have been added to the federal supply contract between Downeast Logistics and the federal government and is approved for purchase by all facilities, thereby reducing the time associated with approval at each individual facility.